Qualitative Study of Suicidal Recrudescence Among Adolescents in November 2021
Launched by FONDATION LENVAL · Mar 21, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the experiences of adolescents who sought help during a time of increased suicidal thoughts, particularly during November 2021. Researchers want to understand what these young people went through, as well as how their families, teachers, and healthcare providers perceived their struggles. By talking to participants through interviews, the study aims to gather detailed insights into the reasons behind the rise in suicidal crises during this period, especially in the context of challenges related to COVID-19.
To be eligible for this study, participants must be between the ages of 13 and 17 years old and have visited a child psychiatric emergency room for suicidal thoughts during November 2021. They should also be able to understand and communicate in French and have consent from themselves and a parent or guardian to participate. Those who join the study can expect to share their experiences in a supportive environment where their voices will contribute to a better understanding of youth mental health during difficult times.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient having consulted in the child psychiatric emergency room of the HPNCL between November 1, 2021 and November 30, 2021 for suicidal thoughts.
- • Age between 13 years and 17 years and 11 months
- • Good understanding of written and oral French
- • Collection of the informed consent of the patient and of one of the two parents or holder of parental authority
- Exclusion Criteria:
- • Inability to comply with the instructions defined and exposed during inclusion
- • Refusal of participation by the patient or one of the legal guardians
About Fondation Lenval
Fondation Lenval is a prominent clinical trial sponsor dedicated to advancing pediatric healthcare through innovative research and development. Based in Nice, France, the foundation focuses on improving treatments and outcomes for children with various medical conditions, particularly in the fields of neonatology and pediatrics. By collaborating with leading healthcare professionals and institutions, Fondation Lenval aims to bridge the gap between clinical practice and research, ensuring that its studies adhere to the highest ethical standards and regulatory requirements. Through its commitment to enhancing child health and well-being, the foundation plays a crucial role in shaping the future of pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, France
Patients applied
Trial Officials
Louise-Emilie DUMAS, MD
Principal Investigator
Fondation Lenval
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials